LEAP India and Molbio Diagnostics Gain SEBI Approval for Initial Public Offerings
LEAP India and Molbio Diagnostics have received SEBI approval for their initial public offerings.
LEAP India and Molbio Diagnostics have received SEBI approval for their initial public offerings.
Goa-based Molbio closed FY25 with Rs 1,020 crore revenue and Rs 138.5 crore profit, marking a sharp recovery.